Safety and efficacy of NaBen (sodium benzoate)
About this title
Two-part Clinical Study to Evaluate the Safety and Efficacy of NaBen® in Adults with Refractory Schizophrenia
Read the official source — EUCTR 2017-001170-42This historical record does not confirm current site availability.
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Gdańsk and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
This is historical registry information. What is the current study status and protocol?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 287
- Sponsor
- SyneuRx International (Taiwan) Corp
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Poland
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2017-001170-42
- Official title
Show the full official title
An adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase In...
Recruitment & locations
Gdańsk · Lublin · Wroclaw
Registry details
Original registry record (opens in a new tab)- Poland — Ongoing, recruiting
- Germany — Ongoing
- United Kingdom — GB - no longer in EU/EEA
- Poland — Trial now transitioned
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is SyneuRx International (Taiwan) Corp.
Is this study still recruiting?
The registry lists this study as recruiting.
